| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $27.46M | $11.01M | – | $22.60M | $17.93M |
| R&D | $3.73M | $7.62M | $17.03M | $16.32M | $11.83M |
| SG&A | $3.25M | $3.18M | $5.24M | $6.28M | $6.11M |
| Operating Income | – | – | -$22.27M | – | – |
| Interest Expense | $982.00K | $483.00K | -$2.19M | $67.00K | $212.00K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$26.49M | -$7.28M | $19.98M | $21.76M | $17.83M |
| EPS (basic) | 0.0270 | 4.4400 | 22133294.0000 | – | – |
| EPS (diluted) | 0.0270 | 4.9900 | 22133294.0000 | – | – |
| Shares (diluted) | $480.05K | $1.64M | – | – | – |